Emergent BioSolutions
EBS
#8534
Rank
HK$2.07 B
Marketcap
HK$40.38
Share price
-6.36%
Change (1 day)
-47.56%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -HK$39.46

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -HK$39.52. In 2025 the company made an earnings per share (EPS) of HK$7.45 an increase over its 2024 EPS that were of -HK$28.46.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$39.46-629.83%
2025HK$7.45-126.17%
2024-HK$28.46-75.61%
2023-HK$116.69232.21%
2022-HK$35.13-203.46%
2021HK$33.95-25.09%
2020HK$45.32445.28%
2019HK$8.31-15.2%
2018HK$9.80-35.9%
2017HK$15.2969.57%
2016HK$9.02-27.67%
2015HK$12.4765.62%
2014HK$7.5311.63%
2013HK$6.7432.31%
2012HK$5.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.57-114.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-119.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56-157.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$14.11-64.29%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$4.16-110.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.11-13.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$3.53-108.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel